Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207776 · ClinicalTrials.gov registry record · NA
An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 4,832
- Enrollment target
NCT03207776: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03207776 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 4,832 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (244% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03207776, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,832 participants
- Enrollment target
Study Summary
Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on the pathway will also have access to navigator services.
Primary Outcome
Occurrence of Emergency Department, inpatient, or observation encounters after the initial encounter at accrual
Interventions
- OTHER Usual Care
- OTHER COPD Clinical Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,832 participants |
| Start Date | 2017-06-12 |
| Est. Completion | 2018-08-13 |
| Phase | NA |
What the finished NCT03207776 record still lists
NCT03207776 is an interventional study that assigns participants to a tested intervention. Its 4,832 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (244% higher).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03207776 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03207776 about?
NCT03207776 is a clinical study titled "An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD". Patients who are hospitalized at select Carolinas Healthcare System (CHS) sites with Chronic Obstructive Pulmonary Disorder (COPD) acute exacerbation symptoms will be treated per the CHS COPD Clinical Pathway. Patient outcomes will be followed, including but not limited to readmission. Patients on t...
What is the current status of trial NCT03207776?
This trial is currently completed. It is a NA study. The enrollment target is 4,832 participants. The study started on 2017-06-12. Estimated completion is 2018-08-13.
What interventions are being tested in trial NCT03207776?
The interventions under investigation include: Usual Care (OTHER), COPD Clinical Pathway (OTHER).
Who is sponsoring clinical trial NCT03207776?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03207776's enrollment target sits among peer trials
4,832 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI